Literature DB >> 11402321

Reducing mammary cancer risk through premature stem cell senescence.

C A Boulanger1, G H Smith.   

Abstract

The reproductive capacity of the mammary epithelial stem cell is reduced coincident with the number of symmetric divisions it must perform. In a study of FVB/N mice with the transgene, WAP-TGFbeta1, we discovered that mammary epithelial stem cells were prematurely aged due to ectopic expression of TGF-beta1. To test whether premature aging of mammary epithelial stem cells would have an impact on susceptibility or resistance to mammary cancer, female littermates from FVB/N x WAP-TGF-beta1 mating were injected with mouse mammary tumor virus (MMTV) at 8-10 weeks of age. A total of 44 females were inoculated, maintained as breeders and observed for tumor development for up to 18 months. Only one mammary tumor appeared in 17 TGF-beta1 females while 15 were collected from 29 wild type sisters. Premalignant mammary epithelial cells in infected glands were identified by transplantation of single cell (1 x 10(5)) suspensions into nulliparous hosts and testing for hyperplastic outgrowth. Although the number of positive takes was significantly reduced with TGF-beta1 cells, both MMTV-infected TGF-beta1 and wild type cells produced hyperplastic outgrowths suggesting that premalignant transformation was achieved in each group. The results suggest a positive correlation between the procreative life-span of mammary epithelial stem cells and mammary cancer risk.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402321     DOI: 10.1038/sj.onc.1204312

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

Review 1.  Mammary epithelial stem cells: transplantation and self-renewal analysis.

Authors:  Gilbert H Smith; Corinne A Boulanger
Journal:  Cell Prolif       Date:  2003-10       Impact factor: 6.831

Review 2.  Leukocytes in mammary development and cancer.

Authors:  Lisa M Coussens; Jeffrey W Pollard
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

Review 3.  Pregnancy and stem cell behavior.

Authors:  Kay-Uwe Wagner; Gilbert H Smith
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-01       Impact factor: 2.673

Review 4.  Stem cells, hormones, and mammary cancer.

Authors:  Gilbert H Smith
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 5.  Wnt5a as an effector of TGFβ in mammary development and cancer.

Authors:  Rosa Serra; Stephanie L Easter; Wen Jiang; Sarah E Baxley
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-18       Impact factor: 2.673

Review 6.  The complexities of TGF-β action during mammary and squamous cell carcinogenesis.

Authors:  Erin C Connolly; Rosemary J Akhurst
Journal:  Curr Pharm Biotechnol       Date:  2011-12       Impact factor: 2.837

7.  Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model.

Authors:  Binwu Tang; Naomi Yoo; Mary Vu; Mizuko Mamura; Jeong-Seok Nam; Akira Ooshima; Zhijun Du; Pierre-Yves Desprez; Miriam R Anver; Aleksandra M Michalowska; Joanna Shih; W Tony Parks; Lalage M Wakefield
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

Review 8.  Transforming growth factor beta (TGF-beta) and inflammation in cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-16       Impact factor: 7.638

Review 9.  MMTV-induced pregnancy-dependent mammary tumors : early history and new perspectives.

Authors:  Edith C Kordon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-26       Impact factor: 2.673

10.  Reprogramming cell fates in the mammary microenvironment.

Authors:  Corinne A Boulanger; Gilbert H Smith
Journal:  Cell Cycle       Date:  2009-04-12       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.